Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00275717 · ClinicalTrials.gov registry record
A Study That Will Look at the Impact of Immunosuppression on Antibody Production in Kidney Transplant Recipients.
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 60
- Enrollment target
NCT00275717: Completed study, sponsored by Mayo Clinic.
NCT00275717 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00275717 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
Study Summary
This study is being done to collect blood and bone marrow samples for biologic studies of antibody producing cells. Donor specific antibodies can cause damage to the kidneys after they are transplanted. The study will look at the impact of immunosuppression on antibody production by antibody producing cells.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2005-03 |
| Est. Completion | 2010-12 |
What the finished NCT00275717 record still lists
NCT00275717 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 60 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00275717 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00275717 about?
NCT00275717 is a clinical study titled "A Study That Will Look at the Impact of Immunosuppression on Antibody Production in Kidney Transplant Recipients.". This study is being done to collect blood and bone marrow samples for biologic studies of antibody producing cells. Donor specific antibodies can cause damage to the kidneys after they are transplanted. The study will look at the impact of immunosuppression on antibody production by antibody produci...
What is the current status of trial NCT00275717?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2005-03. Estimated completion is 2010-12.
Who is sponsoring clinical trial NCT00275717?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia